3543 Acid-activated urea channel
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 3 | 0.3 | 9.11× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02451 | BNG | B-nonylglucoside | 5 |
| DB03796 | PLM | Palmitic Acid | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| XP4 | 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHATE | 15 |
| 78M | (2S)-2,3-DIHYDROXYPROPYL(7Z)-PENTADEC-7-ENOATE | 6 |
| BNG | nonyl beta-D-glucopyranoside | 5 |
| PLM | PALMITIC ACID | 3 |